Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
42 studies found for:    " January 16, 2008":" February 15, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed
Has Results
Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & Efficacy
Condition: HIV Infections
Intervention: Drug: tipranavir
22 Completed INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.
Condition: HIV Infections
Interventions: Drug: enfuvirtide [Fuzeon];   Drug: Optimized background ARV therapy
23 Completed Italian Prospective Data Collection for Better Patient Characterization in a Highly Treatment Experienced Population
Condition: HIV Infections
Intervention: Drug: TPV
24 Completed Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy
Condition: HIV Infections
Interventions: Drug: Darunavir 900mg + ritonavir 100 mg once a day;   Drug: Darunavir 600mg + ritonavir 100mg twice day
25 Completed Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours
Condition: HIV Infections
Intervention: Drug: tipranavir/ritonavir (dose reduction)
26 Completed Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women
Conditions: HIV Infections;   Substance Use
Intervention: Behavioral: Safer Sex Skills Building (SSB)
27 Withdrawn Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults
Condition: HIV Infections
Interventions: Biological: DermaVir patch;   Biological: Placebo patch
28 Terminated Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection
Condition: HIV Infections
Interventions: Drug: apricitabine;   Drug: lamivudine
29 Terminated
Has Results
MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection
Condition: HIV Infections
Intervention: Drug: Raltegravir; valproic acid
30 Unknown  Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Lumefantrine-artemether and nevirapine;   Drug: lumefantrine-artemether and efavirenz;   Drug: Lumefantrine-artemether and rifampicin
31 Completed
Has Results
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
Conditions: HIV Infections;   Sexually Transmitted Diseases
Intervention: Biological: Quadrivalent HPV vaccine
32 Completed Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting
Conditions: HIV Infections;   Streptococcus Pneumoniae
Interventions: Biological: pneumococcal conjugate vaccine;   Biological: pneumococcal polysaccharide vaccine
33 Completed
Has Results
TH9507 Extension Study in Patients With HIV- Associated Lipodystrophy
Conditions: Lipodystrophy;   HIV Infections
Interventions: Drug: Tesamorelin;   Drug: Placebo for Tesamorelin
34 Completed Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Nevirapine without dose escalation;   Drug: Nevirapine initiation with dose escalation
35 Unknown  Efficacy of Group Intervention to Reduce Stress Symptoms
Conditions: Stress Disorders, Post-Traumatic;   HIV Infections
Intervention: Behavioral: HIV Skills-based Prevention
36 Completed Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4
Conditions: HIV Infections;   Hepatitis C
Intervention: Drug: Peginterferon alfa-2a + ribavirin
37 Completed Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: rifabutin in combination with efavirenz;   Drug: rifabutin in combination with nevirapine;   Drug: rifabutin in combination with lopinavir/ritonavir
38 Completed HIV and Hepatitis Care Coordination in Methadone Treatment
Conditions: Hepatitis, Viral, Human;   HIV Infections
Interventions: Behavioral: Testing, Education, & Counseling (TEC);   Behavioral: Hepatitis Care Coordination (HCC)
39 Completed An Educational and Supportive Counseling Program for Increasing Antiretroviral Use and Adherence in People With HIV
Condition: HIV
Interventions: Behavioral: Counseling sessions;   Behavioral: Group workshop
40 Unknown  Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV
Conditions: Chronic Hepatitis C;   Co-Infection HIV-HCV
Intervention: Drug: Peg interferon + Ribavirin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.